Autologous treatment for ALS with implication for broad neuroprotection

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is characterized by a progressive loss of motor neurons (MNs), leading to paralysis, respiratory failure and death within 2–5 years of diagnosis. The exact mechanisms of sporadic ALS, which comprises 90% of all cases, remain unknown. In familial ALS, m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Daehwan, Kim, Subin, Sung, Ashley, Patel, Neetika, Wong, Nathan, Conboy, Michael J., Conboy, Irina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915496/
https://www.ncbi.nlm.nih.gov/pubmed/35272709
http://dx.doi.org/10.1186/s40035-022-00290-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915496/
https://www.ncbi.nlm.nih.gov/pubmed/35272709
http://dx.doi.org/10.1186/s40035-022-00290-5

Ejemplares similares